Anduril IPO before 2027?

Market leans towards Anduril not going public before 2027.

The prediction market indicates a 73% probability that Anduril will not have an IPO before 2027, with a lower confidence in the opposing view. The Pulse AI suggests a slightly higher likelihood of 30% for a possible IPO, but overall sentiment remains skeptical. The market appears fairly priced with a confidence level of 60 out of 100.

• 1 Current market sentiment favors a NO outcome for the IPO.
• 2 The probability gap indicates skepticism about a near-term IPO.
• 3 Historical trends in tech IPOs may influence future outcomes.
• 4 Liquidity in this market suggests moderate interest from participants.
• 5 Time pressure is significant with over 7000 hours until expiry.

This market will resolve to "Yes" if the listed company completes an Initial Public Offering (IPO) by December 31, 2026, 11:59 PM ET, as confirmed by official company announcements or credible news sources. The IPO refers to the first sale of stock by the listed company to the public on any recognized stock exchange.

If the listed company merges with another entity, is acquired, or ceases to exist before the market resolves, the market will also resolve to "No".

This market will resolve early if the listed company completes an IPO by December 31, 2026, 11:59 PM ET.

The resolution source for this market is a consensus of credible reporting.